CEACAM5 and breast cancer: Carcinoembryonic antigen (CEA) is a nonspecific serum biomarker, since it appears at elevated levels in different malignant cancers, including colorectal cancer, medullary thyroid cancer, breast cancer, mucinous ovarian cancer, pancreatic cancer, lung cancer, and advanced stages of GC.